Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc CLAZF

Healthcare Biotechnology

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

Add To Watchlist

GREY:CLAZF - Post Discussion

Claritas Pharmaceuticals Inc > Phase one

View:

Post by polo22 on Feb 18, 2022 4:40pm

Phase one

Hey mr Bailey... I much respect your opinion ...
so what's your opinion after today ....are you still excited about this miracle drug call r107. ?

117

Comment

Comment by SeeDonRun on Feb 18, 2022 5:30pm

110

Comment

Comment by PTBailey on Feb 18, 2022 5:36pm

I like R107 but I'm growing concerned about if we are going to get this going or not as there might be a problem. Maybe we haven't started because of something we haven't been made aware of. I hope that is not the case. [/quote] If no NR came out today there must be a last minute hiccup or small glitch. They had to believe they were close to a final decision to go ...more

Comment

Claritas Pharmaceuticals Inc